Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

T-type calcium channel inhibitors for treatment of cancer

A chemotherapeutic agent, channel technology, applied in medical preparations containing active ingredients, screening of compounds, determination/examination of microorganisms, etc. And other issues

Inactive Publication Date: 2015-12-23
CAVION INC
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is also evidence depicting Ca 2+ Regulation of input in electrically non-excitable cells, but this is unlikely to account for the Ca requirement for cell division 2+ input and across the G1 / S boundary
Then, expression of T-type Ca in cancer cells and stem cells 2+ channel, but it is a voltage-gated
Because most types of cancer cells and stem cells do not possess the action potentials thought to be necessary to regulate such voltage-gated channels, little is known about the function or regulation of these channels

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • T-type calcium channel inhibitors for treatment of cancer
  • T-type calcium channel inhibitors for treatment of cancer
  • T-type calcium channel inhibitors for treatment of cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] In this disclosure it is to be appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.

[0020] The present disclosure provides treatments for cancer and neoplastic or proliferative diseases comprising inhibition of T-type Ca 2+ aisle. The inventors have determined that inhibition of T-type Ca 2+ Channel activity, especially by inhibiting T-type Ca in cells when the cell membrane potential is about -90mV 2+ Channel activity can block the progression of neoplastic disease and treat cancer.

[0021] The present invention relates to the discovery that voltage-gated T-type Ca 2+ The channel can be used to treat tumor or cancer cell hyperplasia. Unlike typical...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
electric potential / voltageaaaaaaaaaa
electric potential / voltageaaaaaaaaaa
membrane potentialaaaaaaaaaa
Login to View More

Abstract

Presented herein are compounds that inhibit T-type Ca2+ channel activity in a cell when the cell membrane potential is about -90 mV. Preferred compounds inhibit T-type Ca2+ channel activity with an IC50 of 10 [mu]M or less at a membrane potential of about -90 mV. Preferred compounds show selectivity for inhibiting T-type Ca2+ channel activity at about -90 mV, relative to inhibition of T-type Ca2+ channel activity at about -30 mV to -60 mV, of 10: 1 or less. Also provided are methods for identifying compounds that inhibit T-type Ca2+ channel activity in a cell when the cell membrane potential is about -90 mV, and compounds identified by such methods.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of US Provisional Application No. 61 / 751,038, filed January 10, 2013, the entire disclosure of which is incorporated herein by reference. technical field [0003] The present disclosure relates to therapeutically useful compounds, methods of treatment and methods of identifying therapeutically useful compounds. Background technique [0004] Ca at different points in the cell cycle 2+ Influx is critical for progression, although Ca 2+ The precise roles and pathways through which it functions remain largely elusive. More recently, it has been possible to integrate a pathway 1,2 , that is, Ca 2+ Role of influx in achieving crossing of the G1 / S transition or checkpoint, a growth factor-driven unidirectional step in cell cycle progression. The G1 / S transition functions to integrate information from many fundamental cellular inputs, including growth factor signaling and nutrient avai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/00
CPCG01N33/502G01N33/6872G01N2500/10A61K31/4184A61K31/40A61P1/18A61P15/00A61P17/00A61P25/00A61P35/00A61P43/00A61K45/06A61N5/10
Inventor 劳埃德·S·格雷蒂莫西·麦克唐纳
Owner CAVION INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products